Deprescribing to Reduce Injurious Falls Among Older Adults With Dementia
STOP-FALLS-D
2 other identifiers
interventional
123
1 country
1
Brief Summary
STOP-FALLS-D is an educational intervention to inform and activate patients, their care partner(s), and their primary care providers to work together to reduce use of central nervous system (CNS) active medications and prevent adverse outcomes (falls and injuries) associated with their use.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2023
CompletedStudy Start
First participant enrolled
February 22, 2023
CompletedFirst Posted
Study publicly available on registry
March 21, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2023
CompletedResults Posted
Study results publicly available
May 7, 2024
CompletedMay 7, 2024
May 1, 2024
3 months
February 3, 2023
March 5, 2024
May 6, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Participants With Dementia With Medically Treated Falls
Number of older adult participants with dementia with a fall-related healthcare visit
Through study completion, up to 6 months
Secondary Outcomes (2)
Number of Participants With Dementia With All-cause Emergency Department Visits or Hospitalizations
Through study completion, up to 6 months
Number of Participants With Dementia With Skilled Nursing Facility Placement
Through study completion, up to 6 months
Study Arms (1)
Educational Intervention
EXPERIMENTALEducational Intervention
Interventions
This is one-arm, health-system embedded pragmatic pilot trial
Eligibility Criteria
You may qualify if:
- Diagnosed dementia (dementia diagnosis code or prescription for dementia medication)
- Receiving primary care at a Kaiser Permanente Washington integrated group practice outpatient clinic
- Prescribed at least one CNS-active medication on a chronic (3 months or more) basis
You may not qualify if:
- Skilled nursing facility resident
- Current cancer diagnosis
- On hospice or palliative care
- Care Partner Sample
- Aged 18 years or older
- Self-identify as a care partner for the older adult with dementia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Washingtonlead
- National Institute on Aging (NIA)collaborator
Study Sites (1)
Kaiser Permanente Health Research Institute
Seattle, Washington, 98101, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Dr. Elizabeth Phelan
- Organization
- University of Washington
Study Officials
- PRINCIPAL INVESTIGATOR
Elizabeth Phelan, MD
University of Washington
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor: School of Medicine
Study Record Dates
First Submitted
February 3, 2023
First Posted
March 21, 2023
Study Start
February 22, 2023
Primary Completion
May 31, 2023
Study Completion
December 15, 2023
Last Updated
May 7, 2024
Results First Posted
May 7, 2024
Record last verified: 2024-05